Admission Date:  [**2130-8-22**]              Discharge Date:   [**2130-8-30**]  Date of Birth:  [**2062-8-9**]             Sex:   F  Service: SURGERY  Allergies: Tetracycline Analogues / Streptomycin / Ciprofloxacin / Penicillin V Potassium / Vicodin / Iodine / NSAIDS (Non-Steroidal Anti-Inflammatory Drug) / angiogram dye  Attending:[**First Name3 (LF) 301**] Chief Complaint: Cholelithiasis status post endoscopic retrograde cholangiopancreatography for choledocholithiasis.
Past Medical History: PMH: - COPD, continues to smoke, not on home oxygen - H/o pulmonary nodules followed for several years - CAD s/p CABG (4 vessel in [**2116**], one vessel occluded on cath [**2118**], no stents) - Perforated ulcer - [**2125**] ex-lap, was H pylori positive - Uterine CA -s/p TAH BSO - 40 years ago  PSH: - CABG ([**2116**]) - Appendectomy - Tonsillectomy - Bladder suspension procedure - Eye surgery x 3 - TAH/BSO (40 years ago) - Ex-lap for perforated ulcer repair ([**2125**])  Social History: Retired claims adjustor, lives at home with spouse and current 1ppd smoker, 4-6 beers/day.
Family History: Breast/ovarian cancer   Physical Exam: Upon Discharge: Vitals - 98.1  98.0  96  150/86  22  95%3L Gen - AAOx3, NAD CV - +S1/S2, no murmurs/rubs/gallops Resp - distant breath sounds bilaterally, diffuse occasional coarse breath sounds and crackles diffusely, no wheezes/rhonchi Abd - soft, non-tender, non-distended, +BS, no rebound/rigidity/guarding, no palpable masses Inc - clean/dry/intact, no erythema/drainage/induration Ext - no cyanosis/clubbing/edema  Pertinent Results: OPERATIVE PATHOLOGY ([**2130-8-22**]): Gall bladder, cholecystectomy: adenocarcinoma of the gallbladder with associated high-grade dysplasia.
CHEST X-RAY ([**2130-8-25**]): Enlargement of the peripheral consolidative abnormality at the left lung base since [**8-24**] is consistent with increasing infection or infarction.
These diagnostic possibilities were discussed by Dr. [**Last Name (STitle) **] [**Last Name (STitle) 151**] the physician caring for this patient at approximately 11:30 this morning.
V/Q SCAN ([**2130-8-25**]): Low likelihood ratio for recent pulmonary embolism.
CHEST X-RAY ([**2130-8-28**]): Left lower lobe opacification with associated pleural effusion, consistent with pneumonia in the appropriate clinical setting.
LABS UPON DISCHARGE:  [**2130-8-30**] 04:33AM BLOOD WBC-8.6 RBC-3.03* Hgb-10.2* Hct-30.6* MCV-101* MCH-33.8* MCHC-33.5 RDW-13.3 Plt Ct-293 [**2130-8-30**] 04:33AM BLOOD Plt Ct-293 [**2130-8-30**] 04:33AM BLOOD Glucose-103* UreaN-7 Creat-0.4 Na-134 K-4.0 Cl-100 HCO3-24 AnGap-14 [**2130-8-26**] 01:42AM BLOOD ALT-18 AST-22 AlkPhos-74 Amylase-18 TotBili-0.9 [**2130-8-30**] 04:33AM BLOOD Calcium-8.0* Phos-3.3 Mg-1.9  Brief Hospital Course: The patient was admitted to the General Surgical Service for evaluation and treatment.
Pulmonary: On POD2 patient has an episode of desaturation to the mid 70's which was transient and imporved with IS usage and O2 per nasal cannula.
Pateint was hemodynamicaly stable, O2 saturation remained above 90 with supplemental oxygen and UOP was sufficient.
WBC was however elevated at 18 and the decision was made to transfer the patient to the ICU for a further w/u of altered mental status.
Blood gases were followed closely and the patient was continued on supplemental oxygen.
ID: The patient's white blood count and fever curves were closely watched for signs of infection throughout her stay.
Hematology: The patient's complete blood count was examined routinely; no transfusions were required.
Based upon the operative pathology, the Liver experts and Hematology/Oncology team were consulted.
Fluticasone-Salmeterol Diskus (100/50) 1 INH IH [**Hospital1 **] 12.
OxycoDONE (Immediate Release)  5-10 mg PO Q4H:PRN pain RX *oxycodone 5 mg [**12-19**] tablet(s) by mouth every four (4) hours Disp #*40 Tablet Refills:*0   Discharge Disposition: Extended Care  Facility: [**Location (un) 25112**]  - [**Doctor Last Name **] Ponds  Discharge Diagnosis: Cholelithiasis status post endoscopic retrograde cholangiopancreatography for choledocholithiasis.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 304**], MD Phone:[**Telephone/Fax (1) 2723**] Date/Time:[**2130-9-8**] 1:45  Provider: [**Name Initial (NameIs) 394**]/[**Name8 (MD) **] MD Phone:[**Telephone/Fax (1) 253**] Date/Time:[**2130-9-12**] 9:00    Completed by:[**2130-8-30**
